Epidemiology of clostridium difficile colitis in hospitalized patients with inflammatory bowel diseases

Diseases of the Colon and Rectum

Volumn 52, Issue 1, 2009, Pages 40-45

  Ricciardi, Rocco ^a,b,c,e   Ogilvie Jr , James W ^c   Roberts, Patricia L ^a   Marcello, Peter W ^a   Concannon, Thomas W ^b   Baxter, Nancy N ^d  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clostridium difficile; Crohn's disease; Epidemiology; Inflammatory bowel disease; Pseudomembranous; Ulcerative colitis

Indexed keywords

ARTICLE; BACTERIAL INFECTION; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; CROHN DISEASE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; INTESTINE INFECTION; INTESTINE SURGERY; MAJOR CLINICAL STUDY; PARASITOSIS; PREVALENCE; SURGICAL MORTALITY; ULCERATIVE COLITIS; UNITED STATES; CLOSTRIDIUM INFECTION; COLITIS; HOSPITALIZATION; MICROBIOLOGY; MORTALITY; SURVIVAL RATE;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COLITIS; COLITIS, ULCERATIVE; CROHN DISEASE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; PREVALENCE; SURVIVAL RATE; UNITED STATES;

EID: 64049106774     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e31819733fd     Document Type: Article

References (23)

1. Jewell DP. Ulcerative colitis. In: Gastrointestinal and liver disease: pathophysiology, diagnosis, management. In: Feldman M, Scharschmidt BF, Sleisenger MH, eds. Philadelphia: WB Saunders, 1998:1735.
2. Hiatt RA, Kaufman L. Epidemiology of inflammatory bowel disease in a defined northern California population. West J Med 1988;149:541.
3. Ricciardi R, Rothenberger DA, Madoff RD, Baxter NN. Rising prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg 2007; 142:624-31.
4. P2pin J, Valiquette L, Alary ME, et al. Clostridium difficileassociated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 2004; 171:466-72.
5. Dallal RM, Harbrecht BG, Boujoukas AJ, et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 2002;235:363-72.
6. Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005;366:1079-84.
7. Bendle J, James PA, Bennett PM, Avison MB, MacGowanc AP, Al-Shafi KM. Resistance determinants in strains of Clostridium difficile from two geographically distinct populations. Int J Antimicrob Agents 2004;24:619-21.
8. Dimick JB, Wainess RM, Cowan JA, Upchurch GR Jr, Knol KA, Colletti LM. National trends in the use and outcomes of hepatic resection. J Am Coll Surg 2004;199:31-8.
9. Rathore SS, Epstein AJ, Volpp KG, Krumholz HM. Hospital coronary artery bypass graft surgery volume and patient mortality. Ann Surg 2004;239:110-7.
10. Shen JJ, Washington EL, Aponte-Soto L. Racial disparities in the pathogenesis and outcomes for patients with ischemic stroke. Manag Care Interface 2004;17:28-34.
11. Surveillance, Epidemiology, and End Results Program website. Statistical Research & Applications Branch - Joinpoint Home. Available at: http://srab.cancer.gov/joinpoint/. Accessed February 20, 2006.
12. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000;19:335-51. Erratum in: Stat Med 2001;20:655.
13. Miner PB. Factors influencing the relapse of patients with inflammatory bowel disease. Am J Gastroenterol 1997;92(Suppl 12): S1-4.
14. Ardizzone S, Bianchi Porro G. Biologic therapy for inflammatory bowel disease. Drugs 2005;65:2253-86.
15. Chan KL, Sung JY, Hsu R, Liew CT. The association of the amoebic colitis and chronic ulcerative colitis. Singapore Med J 1995;36:303-5.
16. Hernandez GA, Appleyard CB. Bacterial load in animal models of acute and chronic Freactivated' colitis. Digestion 2003;67:161-9.
17. Hermens DJ, Miner PB Jr. Exacerbation of ulcerative colitis. Gastroenterology 1991;101:254-62.
18. Kochhar R, Ayyagari A, Goenka MK, Dhali GK, Aggarwal R, Mehta SK. Role of infectious agents in exacerbations of ulcerative colitis in India. A study of Clostridium difficile. J Clin Gastroenterol 1993;16:26-30.
19. Mylonaki M, Langmead L, Pantes A, Johnson F, Rampton DS. Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool. Eur J Gastroenterol Hepatol 2004;16:775-8.
20. Meyer AM, Ramzan NN, Loftus EV Jr, Heigh RI, Leighton JA. The diagnostic yield of stool pathogen studies during relapses of inflammatory bowel disease. J Clin Gastroenterol 2004;38: 772-5.
21. Vilalta Castel E, Alcazar Montero MS, Navarro Gaspar C, Gimeno Aranguez M. Role of Clostridium difficile infection in the relapse of ulcerative colitis. An Med Interna 2002;19: 637-9.
22. Gryboski JD. Clostridium difficile in inflammatory bowel disease relapse. J Pediatr Gastroenterol Nutr 1991;13:39-41.
23. Weber P, Koch M, Heizmann WR, Scheurlen M, Jenss H, Hartmann F. Microbic superinfection in relapse of inflammatory bowel disease. J Clin Gastroenterol 1992;14:302-8.